ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Staff

Follow Staff: Website |


Saudi Arabia death tool rises to 17 from SARS-like virus

Saudi Arabia death tool rises to 17 from SARS-like virus

May 23, 2013 8:01 am by | 0 Comments

DUBAI (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to ... Read more

Johnson & Johnson plans to submit 10 new products for approval by 2017

Johnson & Johnson plans to submit 10 new products for approval by 2017

May 23, 2013 7:56 am by | 0 Comments

May 23 (Reuters) - Johnson & Johnson said on Thursday that it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis ... Read more


GSK pandemic flu shot may raise narcolepsy risks for adults

GSK pandemic flu shot may raise narcolepsy risks for adults

May 23, 2013 7:13 am by | 0 Comments

HELSINKI/LONDON (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health ... Read more

Merck’s insomnia drug deemed safe at low dose, but not at higher

Merck’s insomnia drug deemed safe at low dose, but not at higher

May 22, 2013 4:14 pm by | 0 Comments

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts ... Read more

SAP partners with start-up to hire people with autism

SAP partners with start-up to hire people with autism

May 22, 2013 1:59 pm by | 0 Comments

FRANKFURT (Reuters) - German software company SAP is looking to recruit people with autism as programmers and product testers, drawing on skills that can include a close attention to detail ... Read more

Oncolytics gets good news on cancer drug Reolysin

Oncolytics gets good news on cancer drug Reolysin

May 22, 2013 9:46 am by | 0 Comments

(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients ... Read more

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

May 22, 2013 8:52 am by | 0 Comments

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for ... Read more


GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

May 22, 2013 7:01 am by | 0 Comments

LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and ... Read more

Immunotherapy: The biggest drug class in history?

Immunotherapy: The biggest drug class in history?

May 22, 2013 5:33 am by | 0 Comments

* Potential sales of $35 bln a year over next 10 years - Citigroup* Immunotherapy may be used in up to 60 percent of cancers* Bristol-Myers Squibb and Roche both ... Read more

Merck signs buyback agreement to strengthen shareholder value

Merck signs buyback agreement to strengthen shareholder value

May 21, 2013 10:30 pm by | 0 Comments

(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up ... Read more

Asthma drug slashes episodes by 87% in mid-stage trial

Asthma drug slashes episodes by 87% in mid-stage trial

May 21, 2013 8:16 am by | 0 Comments

May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making ... Read more

Stock rises for AcelRX as pain management drug device succeeds in late-stage study

Stock rises for AcelRX as pain management drug device succeeds in late-stage study

May 21, 2013 8:12 am by | 0 Comments

(Reuters) - AcelRX Pharmaceuticals Inc said its experimental drug device to treat post-operative pain met the main goal of controlling pain in a late-stage study among patients who had undergone ... Read more

Vaccine to protect children against Japanese Encephalitis approved in U.S.

Vaccine to protect children against Japanese Encephalitis approved in U.S.

May 21, 2013 2:47 am by | 0 Comments

VIENNA (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it ... Read more

English farmers first to get Merck’s new vaccine for cows and sheep

English farmers first to get Merck’s new vaccine for cows and sheep

May 20, 2013 7:05 pm by | 0 Comments

LONDON (Reuters) - British farmers will be the first in Europe to get a vaccine against Schmallenberg virus, a new livestock disease that hit the continent in 2011.Britain's Department for ... Read more

Pfizer halts study of inotuzumab ozogamicin for lymphoma

Pfizer halts study of inotuzumab ozogamicin for lymphoma

May 20, 2013 5:47 pm by | 0 Comments

(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a ... Read more